Honglei Feng - Publications

Prognostic value of composite inflammatory prognostic model in pancreatic cancer.

Journal: Molecular and cellular probes

Published: September 19, 2025

The prognostic value of protein induced by vitamin K absence or antagonist-II in hepatocellular carcinoma patients undergoing surgical resection.

Journal: European journal of gastroenterology & hepatology

Published: July 08, 2025

Prediction of trough concentration and ALK occupancy in plasma and cerebrospinal fluid using physiologically based pharmacokinetic modeling of crizotinib, alectinib, and lorlatinib.

Journal: Frontiers in pharmacology

Published: June 04, 2023

WITHDRAWN: Effect of shRNA‑mediated knockdown EBF1 gene expression on the proliferation of lung cancer cell line A549 in vitro and in vivo.

Journal: Oncology reports

Published: August 29, 2022

Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019.

Journal: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Published: November 11, 2021

Serum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer.

Journal: Cancer management and research

Published: February 22, 2021

Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics.

Journal: World journal of surgical oncology

Published: January 10, 2021

Linear and Nonlinear Two-Terminal Spin-Valve Effect from Chirality-Induced Spin Selectivity.

Journal: ACS nano

Published: November 02, 2020

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.

Journal: BMC cancer

Published: October 22, 2020

EphA2‑enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer.

Journal: Molecular medicine reports

Published: February 25, 2020